Home / CCM2 Knockout Cell Lines

CCM2 Knockout Cell Lines

Gene: CCM2

Official Full Name: CCM2 scaffold proteinprovided by HGNC

Gene Summary: This gene encodes a scaffold protein that functions in the stress-activated p38 Mitogen-activated protein kinase (MAPK) signaling cascade. The protein interacts with SMAD specific E3 ubiquitin protein ligase 1 (also known as SMURF1) via a phosphotyrosine binding domain to promote RhoA degradation. The protein is required for normal cytoskeletal structure, cell-cell interactions, and lumen formation in endothelial cells. Mutations in this gene result in cerebral cavernous malformations. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Nov 2009]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO02234 CCM2 Knockout cell line (HeLa) Human CCM2 1:3~1:6 Negative Online Inquiry
KO02235 CCM2 Knockout cell line (HCT 116) Human CCM2 1:2~1:4 Negative Online Inquiry
KO02236 CCM2 Knockout cell line (HEK293) Human CCM2 1:3~1:6 Negative Online Inquiry
KO02237 CCM2 Knockout cell line (A549) Human CCM2 1:3~1:4 Negative Online Inquiry

Background

CCM2 Gene Knockout Cell Lines are specifically engineered cellular models designed to facilitate the study of Cerebral Cavernous Malformation (CCM) pathophysiology. By selectively disrupting the CCM2 gene, these cell lines allow researchers to investigate the downstream effects of genetic alterations associated with this vascular disorder. The knockout mechanism not only enables the examination of gene function but also elucidates the roles of CCM2 in cellular processes such as angiogenesis, endothelial cell behavior, and vascular integrity.

The key function of the CCM2 Gene Knockout Cell Lines lies in their ability to mimic the altered cellular environments of CCM. Researchers can utilize these models to study changes in cellular signaling pathways, apoptosis, and cell migration, which are crucial for understanding vascular malformations and potential therapeutic interventions. This product's application in clinical and preclinical settings is invaluable for drug discovery, biomarker development, and the exploration of personalized medicine approaches for patients affected by CCM.

Compared to alternative models, such as wild-type cell lines or transient knockout systems, CCM2 Gene Knockout Cell Lines offer a stable platform with consistent genetic changes that can be propagated over multiple passages, ensuring reproducibility in experiments. Moreover, these cell lines provide a more physiologically relevant environment for researchers aiming to develop targeted therapies.

For researchers and clinicians in the fields of vascular biology and genetic disorders, CCM2 Gene Knockout Cell Lines represent a pivotal resource that advances both basic and translational research. By employing these advanced cellular models, scientists can better understand disease mechanisms, which leads to informed therapeutic strategies and improved patient outcomes.

Our company specializes in providing high-quality biological products tailored for research applications. With a commitment to scientific excellence and innovation, we ensure that our products meet the rigorous standards necessary for advanced biomedical research, empowering researchers to explore new frontiers in health and disease.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.